chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Dizziness, Fatigue, Headache
Clinical narrative: Dizziness; Body aches; Severe diarrhea; Vomiting; Headache; Joint pain; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 10:30 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to medications, food, or other products. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and LOGESTERON taken for unknown indications from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Apr2021 at 21:00, the patient experienced severe diarrhoea and vomiting, headache, body aches, joint pain, dizziness and fatigue, all for over 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events severe diarrhea, vomiting, headache, body aches, joint pain, dizziness and fatigue were not resolved.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vomiting
Clinical narrative: Dizziness; Body aches; Severe diarrhea; Vomiting; Headache; Joint pain; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 10:30 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to medications, food, or other products. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and LOGESTERON taken for unknown indications from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Apr2021 at 21:00, the patient experienced severe diarrhoea and vomiting, headache, body aches, joint pain, dizziness and fatigue, all for over 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events severe diarrhea, vomiting, headache, body aches, joint pain, dizziness and fatigue were not resolved.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass
Clinical narrative: left armpit swollen, lump is sensitive soft and warm to touch; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 06Apr2021 at 10:45 (at the age of 60-year-old) as a single dose for COVID-19immunisation. Medical history included cholesterol high and sulfonamide allergy. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN) , GUMMY VI for unknown indication on an unknown date, magnesium (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN), all for unknown indication, from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 12:00 the patient experienced left armpit swollen, lump is sensitive soft and warm to touch. It was unknown whether therapeutic measures were taken as a result of the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event left armpit swollen, lump is sensitive soft and warm to touch was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain in extremity
Clinical narrative: Sore arm; Chills; Fatigue; This is a spontaneous report from a contactable consumer. An elderly non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not reported), via an unspecified route of administration in left arm on 07Apr2021 at 08:00 at single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to vaccination, the patient was diagnosed with COVID-19). Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021, the patient experienced sore arm, chills and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of sore arm, chills and fatigue was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Lethargy, Vomiting
Clinical narrative: Lethargic; Severe vomiting; Very severe  diarrhea; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 01Apr2021 at 09:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included mild heart issue (heart disorder). The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021, the patient experienced lethargic, severe vomiting, very severe diarrhea and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events lethargic, severe vomiting, very severe diarrhea and chills were not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis, Headache
Clinical narrative: Nose bleeds every 12 hours; Starting to get headaches; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 05Apr2021 at 13:00 (at the age of 22-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma as a kid. The patient had history of known allergies to cefalexin (KEFLEX). Concomitant medication included sertraline hydrochloride (ZOLOFT); from an unknown date for unknown indication. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 04:00, the patient had nose bleeds in every 12 hours and started to get headaches. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of reported events. The clinical outcome of nose bleeds every 12 hours and headache was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Lip swelling, Mouth swelling, Paraesthesia
Clinical narrative: Lightheaded; Red face; swelling of tongue.; swelling of throat; swelling lips; swelling mouth; Tingling face, neck, chest, and arms and hands; This is a spontaneous report from a contactable healthcare professional, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the left arm on 18Mar2021 at 11:30 (at the age of 39-year-old), as a single dose for COVID-19 immunisation. Medical history  was reported as none  and the patient had a history of allergy to sulfa drugs, shellfish and experienced rash and lip swelling respectively. The patient did not receive any other medication within two weeks of vaccination. The patient previously received vancomycin for unknown indication and experienced rash. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 11:30, the patient experienced lightheaded, red face, tingling of face, neck, chest, arms, hands and slight swelling of tongue, throat, lips, mouth. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lightheaded, red face,  tingling face, neck, chest, arms, hands and swelling of tongue, swelling throat, lips, mouth was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Swollen tongue
Clinical narrative: Lightheaded; Red face; swelling of tongue.; swelling of throat; swelling lips; swelling mouth; Tingling face, neck, chest, and arms and hands; This is a spontaneous report from a contactable healthcare professional, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the left arm on 18Mar2021 at 11:30 (at the age of 39-year-old), as a single dose for COVID-19 immunisation. Medical history  was reported as none  and the patient had a history of allergy to sulfa drugs, shellfish and experienced rash and lip swelling respectively. The patient did not receive any other medication within two weeks of vaccination. The patient previously received vancomycin for unknown indication and experienced rash. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 11:30, the patient experienced lightheaded, red face, tingling of face, neck, chest, arms, hands and slight swelling of tongue, throat, lips, mouth. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lightheaded, red face,  tingling face, neck, chest, arms, hands and swelling of tongue, swelling throat, lips, mouth was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Swelling, Urticaria
Clinical narrative: Hives; swelling; shortness of breath; chest tightness; This is a spontaneous report from a contactable consumer (patient) via COVAES. This 37-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number ER8732) via an unspecified route of administration in the left arm on 05Apr2021 at 08:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies, mild asthma, reflex sympathetic dystrophy (RSD), and known allergies to apples and melons, all from unknown dates and unknown if ongoing. The patient did not receive any other vaccines in the 4 weeks prior to the COVID vaccine. Concomitant medications included amoxicillin, clavulanate potassium (AUGMENTIN); cetirizine hydrochloride (ZYRTEC); and montelukast sodium (SINGULAIR); all from unknown dates for unknown indications. The patient previously received the first dose of BNT162B2 (lot number EN6207) in the left arm on 15Mar2021 at 14:00 (at 37-years-old) for COVID-19 immunisation. On 05Apr2021 at 10:15 the patient experienced hives, swelling, shortness of breath, and chest tightness. The events were reported as non-serious and did not require hospitalization. The events required an emergency department visit and the patient was treated with intravenous medications. The clinical outcomes of hives, swelling, shortness of breath, and chest tightness were unknown. Since vaccination the patient had not been tested for COVID-19.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea, Headache, Infrequent bowel movements, Insomnia
Clinical narrative: 18hr post, start BMs, 21hr post, last diarrhea;; 18hr post, start BMs, 21hr post, last diarrhea;; Digestive track upset, no pain, but uncomfortable enough for no sleep;; Salivating with upset stomach; Salivating with upset stomach/ digestive track upset/ Digestive issue not related to food/drink/still mild tummy upset; Mild headache; Mild sore arm; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 60-year-old) as single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Concomitant medications included diclofenac 75mg (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), vitamin d nos (VIT D) and centrum silver (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 11:30 hours (at the age of 60-year-old) as single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 07Apr2021, after 8-hours of receiving 2nd vaccine, the patient experienced mild headache, mild sore arm, and took TYLENOL. After 10-hours, the patient was salivating with upset stomach but no nausea. After 12-hours, the patient took TUMs and had digestive track upset, no pain, but uncomfortable enough, for disturbed sleep. Post 18-hours of vaccination, the patient had BMs (infrequent bowel movements). On 08Apr2021, after 21hr the patient had last episode of diarrhoea. On 08Apr2021, after 24-hour the patient had mild headache and still mild tummy upset. The patient felt that digestive issue was not related to food or drink and can only be attributed to vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of mild headache, pain in arm which included treatment with acetaminophen (TYLENOL) and for the event stomach upset with calcium carbonate (TUMs) on 07Apr2021. The clinical outcome of the event diarrhoea was recovered on an unknown on 08Apr2021, while that of the events of headache, pain in arm, salivation, stomach upset, sleep loss, infrequent bowel movements was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Salivary hypersecretion
Clinical narrative: 18hr post, start BMs, 21hr post, last diarrhea;; 18hr post, start BMs, 21hr post, last diarrhea;; Digestive track upset, no pain, but uncomfortable enough for no sleep;; Salivating with upset stomach; Salivating with upset stomach/ digestive track upset/ Digestive issue not related to food/drink/still mild tummy upset; Mild headache; Mild sore arm; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 60-year-old) as single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Concomitant medications included diclofenac 75mg (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), vitamin d nos (VIT D) and centrum silver (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 11:30 hours (at the age of 60-year-old) as single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 07Apr2021, after 8-hours of receiving 2nd vaccine, the patient experienced mild headache, mild sore arm, and took TYLENOL. After 10-hours, the patient was salivating with upset stomach but no nausea. After 12-hours, the patient took TUMs and had digestive track upset, no pain, but uncomfortable enough, for disturbed sleep. Post 18-hours of vaccination, the patient had BMs (infrequent bowel movements). On 08Apr2021, after 21hr the patient had last episode of diarrhoea. On 08Apr2021, after 24-hour the patient had mild headache and still mild tummy upset. The patient felt that digestive issue was not related to food or drink and can only be attributed to vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of mild headache, pain in arm which included treatment with acetaminophen (TYLENOL) and for the event stomach upset with calcium carbonate (TUMs) on 07Apr2021. The clinical outcome of the event diarrhoea was recovered on an unknown on 08Apr2021, while that of the events of headache, pain in arm, salivation, stomach upset, sleep loss, infrequent bowel movements was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus
Clinical narrative: Itchy bumps; Pain in the arm; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Apr2021 at 10:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included headache. It was reported that the patient was allergic to a component of the pfizer vaccine. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) taken for unrelated headache. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 14Mar2021 at 10:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021, the patient experienced pain in the arm and itchy bumps. The patient reported that in the morning of April 6 hand starting feeling itchy but without bumps. However, around 5 pm the itchy bumps started coming out on left fore arm. It got worst as the night went on and had to take benadryl (MANUFACTURER UNKNOWN) to relieve it then went to sleep and woke up next morning (April 7) to more itching, he guesses the medicine has worn off. It got itchier and the bumps started showing in stomach, upper legs, but cheeks, a few on lower legs, and now also on the right arm. (fore arm and hands mostly). The patient bought CLARITIN, which was 4 times more expensive than benadryl (MANUFACTURER UNKNOWN) but did not work so went back to king benadryl (MANUFACTURER UNKNOWN) and it relieve it for around 6 hours and had to take another 50mg for another 6 hours of relief. On April 8 morning, the bumps have reduced and itchiness was only mild. So have not taken the medicine again yet and usually after 6 hours need to take another benadryl (MANUFACTURER UNKNOWN). Therapeutic measures were taken as a result of the event itchy bumps  which included treatment with benadryl (MANUFACTURER UNKNOWN) and CLARITIN. The clinical outcome of pain in the arm and itchy bumps was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Paraesthesia
Clinical narrative: Discovered swollen lymph node underleft arm due to pain; Discovered swollen lymph node underleft arm due to pain; First 4 hours felt tingling throughout body.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 13:45 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included cervical fusion and associated pain. The patient was allergic to sulfa based. Concomitant medications included escitalopram oxalate (LEXAPRO) 5mg, fish oil (MANUFACTURER UNKNOWN), women's vitamin (MANUFACTURER UNKNOWN) and curcuma longa (TURMERIC); all for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 14:00 after 15 minutes of vaccination, the patient felt tingling throughout body for first 4 hours of vaccination. On 03Apr2021, the day 11 of vaccination the patient experienced swollen lymph node under left arm due to pain and was still present on day 17. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event of tingling throughout body was recovered on 23Mar2021; while that of the event of swollen lymph node under left arm due to pain was not recovered at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Hypertension, Influenza like illness, Pyrexia
Clinical narrative: high bp; high bp and temp; Lungs/rib cage felt tight in certain position; felt more pain in joints; felt more pain in joints and flu like; This is a spontaneous report from a contactable consumer, the patient. An 80-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6206) via an unspecified route of administration in the left arm on 25Mar2021 at 13:00 (at the age of 80-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure (bp), allergy (es) and fibromyalgia (FM) which was ongoing. Concomitant medications included tramadol (MANUFACTURER UNKNOWN) and amlodipine (MANUFACTURER UNKNOWN), both for unknown indications from unknown dates. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021, started during night, lungs/rib cage felt tight in certain position, next morning on 03Apr2021, the patient experienced high bp (blood pressure) and temp (temperature). On an unknown date in 2021, previous during week, the patient felt more pain in joints and flu like, but having FM (fibromyalgia), the patient thought that was the cause. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events lungs/rib cage felt tight in certain position, high bp (blood pressure) and temp (temperature), felt more pain in joints and flu like were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pain in extremity, Pyrexia
Clinical narrative: Body aches; Sore arm; 100.3 fever; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient had a medical history of known allergies to eggs. Concomitant medications included rosuvastatin calcium (CRESTOR); from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 27Mar2021 at 09:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 08Apr2021 at 01:00, the day after vaccine was given, the patient experienced sore arm, 100.3 fever and body aches. No therapeutic measures were taken as a result of the reported events. The clinical outcome of sore arm, 100.3 fever and body aches was resolving at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Pain in extremity
Clinical narrative: Fatigue; Sore arm; Joint pain; Chills; This is a spontaneous report from a contactable non-healthcare professional. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 07Apr2021 at 10:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient had no known past medical history. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) and fluticasone propionate (FLONASE); all from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced fatigue, sore arm, joint pain and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fatigue, sore arm, joint pain and chills were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus, Urticaria
Clinical narrative: Welt on left arm; Tinnitus in right ear; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm left on 10Mar2021 at 11:00(at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol and triglycerides (triglycerides high). Concomitant medications included atorvastatin calcium (LIPITOR), fenofibrate (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA), fluticasone propionate (FLONASE) and beclometasone dipropionate (QVAR) for unknown indication from an unspecified date. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on an unknown date in 2021 (at the age of 52-year- old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021, the patient experienced welt on left arm and tinnitus in right ear. The clinical outcome of the event welt on left arm and tinnitus in right ear was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Back pain, Chills, Diarrhoea
Clinical narrative: Had minor diarrhea the next morning; Throughout 4/6 I felt better, but lightheaded and weak.; Throughout 4/6 I felt better, but lightheaded and weak.; By 5:30pm, I started to have stomach cramps, chills, and more severe body aches (to the point it was painful to move).; By 5:30pm, I started to have stomach cramps, chills, and more severe body aches (to the point it was painful to move).; By 5:30pm, I started to have stomach cramps, chills, and more severe body aches (to the point it was painful to move).; On 4/5 in the morning, I noticed a pain in my back and chalked it up to sleeping wrong.; I was severely nauseous in the middle of thenight; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0150) via an unspecified route of administration in the arm right on 01Apr2021 at 14:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included vitamins (MANUFACTURER UNKNOWN)  from an unknown date and for unknown indication. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 05Apr2021 at 08:00 in the morning, the patient noticed pain in back and chalked it up to sleeping wrong. On 05Apr2021 at 17:30, the patient started to have stomach cramps, chills and more severe body aches (to the point it was painful to move). The patient was severely nauseous in the middle of the night. On 06Apr2021 in the morning, the patient had minor diarrhea and throughout 06Apr2021, she felt better, but was lightheaded and weak. By 07Apr2021, the patient was able to go back to work, but stomach cramping flared up occasionally and was able to eat. The patient found it odd that she would have a reaction after the first shot and 4 days after the injection. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event pain in back, chills, diarrhea, severe body aches and nauseous were recovered on 06Apr2021, while that of lightheaded and weak were recovered on 07Apr2021and that of the event stomach cramps was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pain
Clinical narrative: Had minor diarrhea the next morning; Throughout 4/6 I felt better, but lightheaded and weak.; Throughout 4/6 I felt better, but lightheaded and weak.; By 5:30pm, I started to have stomach cramps, chills, and more severe body aches (to the point it was painful to move).; By 5:30pm, I started to have stomach cramps, chills, and more severe body aches (to the point it was painful to move).; By 5:30pm, I started to have stomach cramps, chills, and more severe body aches (to the point it was painful to move).; On 4/5 in the morning, I noticed a pain in my back and chalked it up to sleeping wrong.; I was severely nauseous in the middle of thenight; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0150) via an unspecified route of administration in the arm right on 01Apr2021 at 14:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included vitamins (MANUFACTURER UNKNOWN)  from an unknown date and for unknown indication. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 05Apr2021 at 08:00 in the morning, the patient noticed pain in back and chalked it up to sleeping wrong. On 05Apr2021 at 17:30, the patient started to have stomach cramps, chills and more severe body aches (to the point it was painful to move). The patient was severely nauseous in the middle of the night. On 06Apr2021 in the morning, the patient had minor diarrhea and throughout 06Apr2021, she felt better, but was lightheaded and weak. By 07Apr2021, the patient was able to go back to work, but stomach cramping flared up occasionally and was able to eat. The patient found it odd that she would have a reaction after the first shot and 4 days after the injection. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event pain in back, chills, diarrhea, severe body aches and nauseous were recovered on 06Apr2021, while that of lightheaded and weak were recovered on 07Apr2021and that of the event stomach cramps was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Headache, Myalgia, Pain
Clinical narrative: Body ache; Weakness; Low grade fever; Headache; Muscle pain; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 05Apr2021 at 11:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 10Mar2021 at 11:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Apr2021 at 16:00, the patient experienced low grade fever, headache, muscle pain, joint pain, weakness and body ache. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of low grade fever, headache, muscle pain, joint pain, weakness and body ache were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Body ache; Weakness; Low grade fever; Headache; Muscle pain; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 05Apr2021 at 11:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 10Mar2021 at 11:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Apr2021 at 16:00, the patient experienced low grade fever, headache, muscle pain, joint pain, weakness and body ache. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of low grade fever, headache, muscle pain, joint pain, weakness and body ache were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: muscle pain, specifically leg, arm; Head pain; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 15:45 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unspecified date. The patient had no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 12:00, the patient experienced muscle pain, specifically leg, arm and head pain. Patient stated that not an adverse effect, just a side effect. Patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events muscle pain, head pain was recovered on an unspecified date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Eye pain, Headache, Paraesthesia, Paraesthesia oral
Clinical narrative: Lightheaded/dizzy; Spotty/cloudy vision; Tongue tingling; Hand tingling; Low grade fever; Headache that moved from forehead to behind left eye; Headache that moved from forehead to behind left eye; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 09:30 (at the age of 20-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to food, medications, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 14:30, the patient experienced face/tongue/hand tingling, low grade fever (reduced with Tylenol), lightheaded/dizzy, spotty/cloudy vision, headache that moved from forehead to behind left eye. On 08Apr2021, the patient underwent nasal swab test for COVID-19 and the result was pending. Therapeutic measures were taken as a result of the event low grade fever which included treatment with TYLENOL. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events face/tongue/hand tingling, low grade fever, lightheaded/dizzy, spotty/cloudy vision, headache that moved from forehead to behind left eye was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Vision blurred
Clinical narrative: Lightheaded/dizzy; Spotty/cloudy vision; Tongue tingling; Hand tingling; Low grade fever; Headache that moved from forehead to behind left eye; Headache that moved from forehead to behind left eye; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 09:30 (at the age of 20-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to food, medications, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 14:30, the patient experienced face/tongue/hand tingling, low grade fever (reduced with Tylenol), lightheaded/dizzy, spotty/cloudy vision, headache that moved from forehead to behind left eye. On 08Apr2021, the patient underwent nasal swab test for COVID-19 and the result was pending. Therapeutic measures were taken as a result of the event low grade fever which included treatment with TYLENOL. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events face/tongue/hand tingling, low grade fever, lightheaded/dizzy, spotty/cloudy vision, headache that moved from forehead to behind left eye was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Pruritus, Rash
Clinical narrative: Stomach ache; rash; itchy; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158), via an unspecified route of administration in the left arm on 07Apr2021 at 10:30 (at the age of 61-year-old), as a single dose for COVID-19 immunisation. Medical history included kidney disease. Concomitant medications were not reported. The patient previously took oxycodone hydrochloride; paracetamol (PERCOCET) and experienced allergy on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced stomach ache, rash and itchy. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event stomach ache, rash and itchy was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.